Skip to main content
TipRanks
Go Ultimate75% OFF

TG Therapeutics (NKB2) Q3 2018 Earnings Report

3 Followers

DE:NKB2 Q3 2018 EPS Results

Actual EPS
-EUR 0.39
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.43

DE:NKB2 Q3 2018 Revenue Results

Actual Revenue
EUR 34.02K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2018
Date
11/09/2018
Time
TBA
Conference Call
Friday, November 9, 2018
DE:NKB2 Upcoming Earnings

TG Therapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q3 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:NKB2 Earnings History

DE:NKB2 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)0.47-0.13――
Nov 09, 20262026 (Q3)0.320.312.18-85.60% (-1.86)
Aug 03, 20262026 (Q2)0.270.040.15-70.59% (-0.11)
May 06, 20262026 (Q1)0.250.110.03300.00% (+0.08)
Feb 26, 20262025 (Q4)0.320.130.13-6.67% (-0.01)
Nov 03, 20252025 (Q3)0.202.180.0212050.00% (+2.16)
Aug 04, 20252025 (Q2)0.190.150.04325.00% (+0.12)
May 05, 20252025 (Q1)0.150.03-0.06142.86% (+0.09)
Mar 03, 20252024 (Q4)0.140.13-0.08266.67% (+0.21)
Nov 04, 20242024 (Q3)0.030.020.65-97.26% (-0.64)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed